The Challenge
A multinational biopharmaceutical company needed to recruit rare autoimmune disease patients for a drug efficacy feasibility study. The incidence rate was extremely low (less than 0.25%), requiring validated doctor referrals and medical records matching.
Our Approach
We structured a qualitative recruitment pipeline combining oncologist/rheumatologist KOL networks and specialized patient support community partnerships. Data was managed via HIPAA-compliant vault architecture.
Results
Successfully identified, screened, and recruited 250 patients globally. Verified 100% of participants against clinical health records.
Client Outcome
The pharmaceutical client successfully determined drug formulation feasibility using verified patient responses, transitioning the study directly to clinical trials.
Project Specifications
- Markets Covered: Global (US, Canada, UK, Germany).
- Audience Recruited: Patients Diagnosed with Rare Autoimmune Disorders.
- Incidence Rate (IR): 0.25% incidence rate.
- Survey length (LOI): 45 Minutes qualitative IDI.
Plan a Similar Study
Ready to execute high-integrity global B2B or consumer research? Contact our fieldwork consultants to design a tailored feasibility plan for your target audience.
Plan a similar study →